All lobbying filings

THE MCMANUS GROUP

THE MCMANUS GROUP filed a Q3 report for ZIMMER BIOMET on October 20, 2025, reporting $50,000 in lobbying income.

Lobbying for ZIMMER BIOMET · A global leader in musculoskeletal healthcare.

All filings by THE MCMANUS GROUP · Everything ZIMMER BIOMET has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$50,000

What the client paid this registrant for the period.

Client based in

Indiana

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Medicare/Medicaid

Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776)

Health Issues

Issues related to Artificial Intelligences approval in Medical Devices.

Taxation/Internal Revenue Code

Issues related to corporate tax policy, including the corporate tax rate, R&D expensing, FDII extension, and implementation of the OECD global minimum tax (Pillar II).

Bills named in this filing 2

H.R. 3006
To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an am…
S. 1776
Medicare Beneficiary Co-Pay Fairness Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.